Get the content you want anytime you want.
ID Week 2018

Select coverage from ID Week 2018 is included below:

Addressing Shortcomings in Infection and Sepsis Treatment Should Be Top of the Priority List
As clinicians and health care executives work to strike a balance between reducing costs and improving clinical outcomes, the importance of sepsis identification and treatment cannot be underscored enough, and starts with evaluating current practices for infection management.
The Fight Against Resistance: Shorter is Better
Brad Spellberg, MD, highlights research that indicate shorter courses of therapy are safer and as effective as longer ones, as well as the importance of randomized controlled trials.
High <i>Toxocara</i> Egg Contamination Found in Areas of Pennsylvania Parks
Highest amounts of Toxocara egg contamination were in areas that could contain food droppings or animal waste.
Iclaprim Non-Inferior to Vancomycin in Treating Patients with Wound Infections
Data from a pooled analysis of the REVIVE-1 and 2 studies found iclaprim to be non-inferior to vancomycin based on earl clinical response in patients with wound infections.
Baloxavir Marboxil Significantly Reduces Time to Improvement of Flu Complications
The phase 3 CAPSTONE-2 trial shows treatment with baloxavir marboxil significantly reduced the time to improvement of flu symptoms compared with placebo.
Top 5 Key Takeaways from ID Week 2018
ID Week 2018 was held October 2-7, 2018, in San Francisco, California. The conference featured results of new studies on a variety of infectious disease topics as well as advancements being made in the field. Here are 5 key takeaways from the meeting. 
Nearly Half of Outpatient Antibiotics Prescribed Without Infection Diagnosis
A study of more than 500 outpatient clinics reveals a new view of antibiotic overprescribing practices in the United States.
Top Takeaways from ID Week 2018
We sat down with several infectious disease experts to learn more about their research and asked them to share what they’re taking home from ID Week 2018.
Big advances in treatment can